Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8952136 Antibodies to human programmed death receptor PD-1

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 23 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 23 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12123003 Synthetic RIG-I-like receptor agonists
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 23 Oct, 2024
Edits on 4 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12077761 Systems and methods for genetic manipulation of
0
Edits on 24 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 22 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11905329 Anti-PD-1 antibodies and uses thereof
0
Edits on 4 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11858991 LAG-3-binding molecules and methods of use thereof
0
Edits on 13 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11840571 Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4
0
Edits on 4 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11827704 Antibody molecules to PD-1 and uses thereof
0
Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article (+252 characters)
Article

Patent abstract

Antibodies which block binding of hPD-1 to hPD-L1 or hPD-L2 and their variable region sequences are disclosed. A method of increasing the activity (or reducing downmodulation) of an immune cell through the PD-1 pathway is also disclosed.

Edits on 2 Nov, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Nov, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11801240 Combination therapies and uses thereof
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Nov, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11802155 ILT-binding agents and methods of use thereof
Edits on 26 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 26 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11708412 Methods for treating hematologic cancers
0
Edits on 31 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11661453 Combination therapies for treating cancer with niraparib and PD-1 inhibitors
0
Edits on 24 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11655303 Anti-CD39 antibody compositions and methods
0
Edits on 24 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0895213600
Edits on 19 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08952136 Antibodies to human programmed death receptor PD-1 US Patent 8952136 Antibodies to human programmed death receptor PD-1

Infobox
Patent Number
0895213600
Patent Number
895213600
Edits on 27 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 27 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
089521360
Date of Patent
February 10, 2015
0
Patent Application Number
137197560
Date Filed
December 19, 2012
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=089521360
Patent Primary Examiner
‌
Ilia Ouspenski
0
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
089521360
Date of Patent
February 10, 2015
0
Patent Application Number
137197560
Date Filed
December 19, 2012
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=089521360
Patent Primary Examiner
‌
Ilia Ouspenski
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=08952136
Edits on 28 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 28 Dec, 2021
Edits made to:
Infobox (+7 properties)
‌

 US Patent 08952136 Antibodies to human programmed death receptor PD-1

Infobox
Is a
Patent
Patent
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08952136
Date of patent
February 10, 2015
Patent application number
13719756
Date Filed
December 19, 2012
Patent primary examiner
‌
Ilia Ouspenski

Find more entities like US Patent 8952136 Antibodies to human programmed death receptor PD-1

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.